Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
10/2005
10/25/2005CA2157191C Process for the hydrogenation of imines
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097813A1 Demethyl-cantharidin platinum complex isomers and their use
10/20/2005WO2005097770A1 Novel hydroxamates as therapeutic agents
10/20/2005WO2005097100A2 Antibacterial agents
10/20/2005WO2005096734A2 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
10/20/2005WO2005066116A8 Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors
10/20/2005WO2005061450A3 Hiv protease inhibiting sulfonamides
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005US20050234269 Homogenous process for the hydrogenation of carboxylic acids and derivatives thereof
10/20/2005US20050234265 2-aminomethyl-5-tert-butyl-3-phenylphenol; antimalaria; used against protozoa of the genus Plasmodium, particularly emerging strains of drug-resistant Plasmodia
10/20/2005US20050234121 coating formulations and polymers that utilize a dioxanone containing composition or fatty acid derivative
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234058 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
10/20/2005US20050234046 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
10/20/2005US20050234040 Tricyclic aromatic and bis-phenyl sulfinyl derivatives
10/20/2005US20050233943 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
10/20/2005CA2561945A1 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
10/20/2005CA2561532A1 Methods for detecting substances which bind to the amyloid precursor protein or beta amyloid fragments, and binding compounds
10/19/2005EP1586569A1 Aryl ethynyl phthalic acid derivative and method for producing the same
10/19/2005EP1586560A1 Thio-substituted arylmethanesulfinyl derivatives
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1585757A2 Peptide deformylase inhibitors
10/19/2005EP1585742A1 Substituted benzoyl derivatives uses as herbicides
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005CN1684944A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/19/2005CN1683353A New process for producing liquid methyl tetrahydro phthalic anhydride
10/19/2005CN1683352A Clary sage lactone synthetic method
10/19/2005CN1223589C Potassium sodium dehydroandroandrographolide succinates and their preparations
10/18/2005US6956988 Optical interleaver
10/18/2005US6956055 Substituted γ-lactone compounds as NMDA-antagonists
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6956004 Vanadium/phosphorus mixed oxide catalyst
10/18/2005US6955838 4,6,7-Trifluoro-benzo[b]naphtho[2,3-d]furan derivatives
10/18/2005CA2190129C Therapeutic phenoxyalkylpyridazines and intermediates therefor
10/13/2005WO2005095410A1 METHODS FOR THE PREPARATION OF (3R,3aS,6aR) HEXAHYDRO-FURO[2,3-b]FURAN-3-OL
10/13/2005WO2005095378A2 Vegetable based dioxanone derivatives, synthesis and uses thereof
10/13/2005WO2005095371A1 Synthesis of chiral furan amino acids as novel peptide building blocks
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005WO2005070910A3 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
10/13/2005WO2005058812A3 Prostaglandin synthesis
10/13/2005WO2005023183A3 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
10/13/2005WO2004099105A3 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
10/13/2005US20050228045 Novel compounds for treatment of cardiac arrhythmia and methods of use
10/13/2005US20050228044 benzodihydrofurans; high activity at PPAR alpha receptor; no activity at PPAR gamma and PPAR delta receptors; atherosclerosis, obesity, and vascular restenosis; 5-{3-[2-Chloro-4-(2,2,2-trifluoro-ethoxy)-phenoxy]-propoxy}-2-methyl-2,3-dihydro-benzofuran-2-carboxylic acid; no 1,3-thiazolidinedione moiety
10/13/2005US20050228043 Preparation of trans-fused 3,3a,8,12b-tetrahydro-2H-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
10/13/2005US20050228015 Substituted heteroaryl- and phenylsulfamoyl compounds
10/13/2005US20050227990 Aminoalkoxy-functional chalcones
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227976 Novel hydroxamates as therapeutic agents
10/13/2005US20050227285 Control of gene expression in eukaryotic cells
10/13/2005US20050226870 Administering anti-inflammatory amount of a purified antibody specific against C5, wherein antibody inhibits the cleavage of C5 into C5a and C5b
10/13/2005CA2560776A1 Vegetable based dioxanone derivatives, synthesis and uses thereof
10/13/2005CA2560773A1 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005CA2559959A1 Methods for the preparation of (3r,3as,6ar) hexahydro-furo[2,3-b]furan-3-ol
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1201235B1 Neuropathy improvers containing nitrogenous compounds as the active ingredient
10/12/2005EP0954522B1 Novel substituted naphthopyrans
10/12/2005CN1681800A Process for preparing prostaglandin derivatives and starting materials for the same
10/12/2005CN1681771A 4-(3, 3-dihalo-allyloxy)phenoxy alkyl derivatives
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681498A Diaryl ethers as opioid receptor antagonist
10/12/2005CN1680392A Preparation of high-purity ginkgolide
10/12/2005CN1680384A Norcantharidin platinum complex and its use
10/12/2005CN1680369A Double ketole colorless benzofuryl ketone compound and its preparation
10/12/2005CN1680351A Process for the production of beraprost and its salts intermediate
10/12/2005CN1680350A Crystalline base of citalopram
10/12/2005CN1680349A Amine compound, electro-photographic photoreceptor using the amine compound and image forming apparatus having the same
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1680298A Material and intermediate for trifluoromethyl-substituted spirocyclic ketoenols
10/12/2005CN1680272A C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides
10/12/2005CN1679556A Valdecoxib compositions
10/12/2005CN1222519C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/12/2005CN1222517C Method for preparing xitaipulan
10/12/2005CN1222374C Extrusion die
10/11/2005US6953858 A phenylalkyl secondary- and tertiary-amides enzyme inhibitors as viricides, for treating AIDS
10/11/2005US6953812 Carboxy and amide containing compound suitable for treatment and/or prevention of diseases wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, diabetes, disorders of the lipid metabolism, such as dyslipidemia
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/06/2005WO2005092904A1 Novel compounds for modulating cell proliferation
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092898A1 The conjugates of a hydrophilic polymer-tripterygium's extracts and the pharmaceutical compositions thereof
10/06/2005WO2005092897A2 2,4,6-phenylsubstituted cyclic ketoenoles
10/06/2005WO2005092876A1 Synthesis of rocaglamide natural products via photochemical generation of oxidopyrylium species
10/06/2005WO2005092875A1 Crystalline citalopram diol intermediate alkali
10/06/2005WO2005092845A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005WO2005092324A1 Ginkgolide compounds, compositions, extracts, and uses thereof
10/06/2005WO2005092316A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005WO2005075446A9 Unsaturated carboxylic acid hemiacetal ester, polymer, and resin composition for photoresist
10/06/2005WO2005074389A3 Process for the synthesis of vitamin d compounds and intermediates for the synthesis of the compounds
10/06/2005WO2005049562A3 Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof
10/06/2005WO2005046599A3 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders
1 ... 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 ... 472